Mydecine Innovations Group Inc.

CSE: MYCO, OTC: NLBIF

Company Overview

Mydecine Innovations Group Inc. is the parent company operating innovative product divisions in the Naturally Sourced Therapies (NST) space. While controlling a variety of Psilocybin and hemp-derived CBD brands that design, manufacture and distribute cutting edge products, the company further enhances its portfolio with numerous cultivation properties, retail locations, and other land assets.

The company is the progressive and innovative Naturally Sourced Therapies (NST) lifestyle group known around the globe. Focusing on the rapidly emerging psilocybin and psychedelic medicines market, the Company's wholly-owned subsidiary 1220611 B .C. Ltd. (operating as Mydecine Group) ("Mydecine") is a vertically integrated company engaged to utilize the vast medicinal, health and wellness capabilities of the various compounds found in mycology as a whole. Established to parallel the early emergence of the industry, Mydecine aims to be a pioneer in the cultivation, processing, product development, and research and development of mycology's exciting compounds through its three divisions, "Mydecine Farms," "Mydecine Wellness" and "Mydecine Labs."

Furthermore, the company's wholly-owned subsidiaries in the hemp-derived CBD space, We are Kured LLC, Drink Fresh Water LLC, Relyfe Brand LLC, Fresh Water CBD LLC and TeaLief Brand LLC have quickly developed into market leaders and maintain extensive retail and cultivation land investments in the United States .

Mydecine Innovations Group recently acquired MindLeap Health.

Management Team

Mr. David Joshua Bartch
CEO, Pres, Interim CFO & Director

Mr. Damon Michaels
Chief Operating Officer

Mr. Robert Roscow
Chief Science Officer

Mr. Benjamin Martch
Chief Marketing Officer & Director

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.

Key Highlights

Market Capitalization
$20,865,536

Shares Outstanding
33,438,200